Meeting
2015 Genitourinary Cancers Symposium
Defects in DNA repair genes and sensitivity to cisplatin based neoadjuvant chemotherapy (NAC) for bladder cancer.
Authors
Elizabeth R. Plimack
Fox Chase Cancer Center, Philadelphia, PA
Elizabeth R. Plimack , Roland Dunbrack Jr., Timothy Brennan , Mark D. Andrake , Yan Zhou , Ilya Serebriiskii , Essel Dulaimi , Jean H. Hoffman-Censits , Marijo Bilusic , Yu-Ning Wong , Alexander Kutikov , Rosalia Viterbo , Richard E. Greenberg , David Y. T. Chen , Costas D. Lallas , Edouard John Trabulsi , Roman Yelensky , Vincent A. Miller , Erica Golemis , Eric A Ross
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session B: Prostate, Penile, Testicular, and Urethral Cancers, and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 320)
DOI
10.1200/jco.2015.33.7_suppl.320
Abstract #
320
Poster Bd #
F7
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Defects in DNA repair genes and long-term survival in cisplatin-based neoadjuvant chemotherapy for muscle invasive bladder cancer (MIBC).
First Author: Benjamin Miron
Poster
2015 ASCO Annual Meeting
Defects in DNA repair genes and sensitivity to cisplatin based neoadjuvant chemotherapy (NAC) for bladder cancer.
First Author: Yu-Ning Wong
Poster
2014 ASCO Annual Meeting
Next-generation sequencing to identify molecular alterations in DNA repair and chromatin maintenance genes associated with pathologic complete response (pT0) to neoadjuvant accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) in muscle-invasive bladder cancer (MIBC).
First Author: Elizabeth R. Plimack
Poster
2023 ASCO Genitourinary Cancers Symposium
FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.
First Author: Srikala S. Sridhar